#CNBC Breen: Tariffs are not really landing on the industry

Breen: Tariffs are not really landing on the industry
Courtney Breen, Senior Research Analyst at Bernstein, says tariffs have minimal pharma impact, Zepbound is rapidly gaining share in obesity drugs, and Amgen remains her top pick amid mixed earnings.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”